# Paylocity Holding Corp: financial statements, quarterly

PCTY · Nasdaq · CIK 1591698 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/pcty.md) · [Financials](/companies/pcty/financials.md) · [Filings](/companies/pcty/filings.md) · [Insiders](/companies/pcty/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pcty/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [292](/filings/0001591698-24-000277.md) | [298](/filings/0001591698-25-000010.md) | [367](/filings/0001591698-25-000051.md) | [325 d](/filings/0001591698-26-000069.md) | [333](/filings/0001591698-25-000113.md) | [348](/filings/0001591698-26-000007.md) | [421](/filings/0001591698-26-000037.md) | [370 d](/filings/0001591698-26-000069.md) | [379](/filings/0001591698-25-000113.md) | [387](/filings/0001591698-26-000007.md) | [470](/filings/0001591698-26-000037.md) | [416 d](/filings/0001591698-26-000069.md) |
| Cost of revenue | $m | [101](/filings/0001591698-24-000277.md) | [107](/filings/0001591698-25-000010.md) | [116](/filings/0001591698-25-000051.md) | [117 d](/filings/0001591698-26-000069.md) | [115](/filings/0001591698-25-000113.md) | [125](/filings/0001591698-26-000007.md) | [130](/filings/0001591698-26-000037.md) | [129 d](/filings/0001591698-26-000069.md) | [128](/filings/0001591698-25-000113.md) | [134](/filings/0001591698-26-000007.md) | [139](/filings/0001591698-26-000037.md) | [144 d](/filings/0001591698-26-000069.md) |
| Gross profit | $m | [216](/filings/0001591698-24-000277.md) | [219](/filings/0001591698-25-000010.md) | [285](/filings/0001591698-25-000051.md) | [240 d](/filings/0001591698-26-000069.md) | [248](/filings/0001591698-25-000113.md) | [252](/filings/0001591698-26-000007.md) | [325](/filings/0001591698-26-000037.md) | [272 d](/filings/0001591698-26-000069.md) | [280](/filings/0001591698-25-000113.md) | [282](/filings/0001591698-26-000007.md) | [363](/filings/0001591698-26-000037.md) | [300 d](/filings/0001591698-26-000069.md) |
| Research and development | $m | [44.6](/filings/0001591698-24-000277.md) | [46.1](/filings/0001591698-25-000010.md) | [43.4](/filings/0001591698-25-000051.md) | [44.2 d](/filings/0001591698-26-000069.md) | [47.3](/filings/0001591698-25-000113.md) | [56.2](/filings/0001591698-26-000007.md) | [51.4](/filings/0001591698-26-000037.md) | [51.0 d](/filings/0001591698-26-000069.md) | [55.6](/filings/0001591698-25-000113.md) | [57.7](/filings/0001591698-26-000007.md) | [52.5](/filings/0001591698-26-000037.md) | [55.5 d](/filings/0001591698-26-000069.md) |
| Operating income | $m | [41.2](/filings/0001591698-24-000277.md) | [49.7](/filings/0001591698-25-000010.md) | [106](/filings/0001591698-25-000051.md) | [62.9 d](/filings/0001591698-26-000069.md) | [64.1](/filings/0001591698-25-000113.md) | [46.6](/filings/0001591698-26-000007.md) | [127](/filings/0001591698-26-000037.md) | [66.2 d](/filings/0001591698-26-000069.md) | [74.2](/filings/0001591698-25-000113.md) | [70.4](/filings/0001591698-26-000007.md) | [157](/filings/0001591698-26-000037.md) | [84.4 d](/filings/0001591698-26-000069.md) |
| Income tax | $m | [9.9](/filings/0001591698-24-000277.md) | [15.4](/filings/0001591698-25-000010.md) | [25.3](/filings/0001591698-25-000051.md) | [19.7 d](/filings/0001591698-26-000069.md) | [19.3](/filings/0001591698-25-000113.md) | [9.4](/filings/0001591698-26-000007.md) | [35.1](/filings/0001591698-26-000037.md) | [18.2 d](/filings/0001591698-26-000069.md) | [26.9](/filings/0001591698-25-000113.md) | [20.0](/filings/0001591698-26-000007.md) | [45.8](/filings/0001591698-26-000037.md) | [24.9 d](/filings/0001591698-26-000069.md) |
| Net income | $m | [34.5](/filings/0001591698-24-000277.md) | [38.1](/filings/0001591698-25-000010.md) | [85.3](/filings/0001591698-25-000051.md) | [48.8 d](/filings/0001591698-26-000069.md) | [49.6](/filings/0001591698-25-000113.md) | [37.5](/filings/0001591698-26-000007.md) | [91.5](/filings/0001591698-26-000037.md) | [48.6 d](/filings/0001591698-26-000069.md) | [48.0](/filings/0001591698-25-000113.md) | [50.2](/filings/0001591698-26-000007.md) | [111](/filings/0001591698-26-000037.md) | [60.3 d](/filings/0001591698-26-000069.md) |
| Diluted EPS | $ per share | [0.61](/filings/0001591698-24-000277.md) | [0.67](/filings/0001591698-25-000010.md) | [1.50](/filings/0001591698-25-000051.md) | not reported | [0.88](/filings/0001591698-25-000113.md) | [0.66](/filings/0001591698-26-000007.md) | [1.61](/filings/0001591698-26-000037.md) | not reported | [0.86](/filings/0001591698-25-000113.md) | [0.92](/filings/0001591698-26-000007.md) | [2.05](/filings/0001591698-26-000037.md) | not reported |
| Basic EPS | $ per share | [0.62](/filings/0001591698-24-000277.md) | [0.68](/filings/0001591698-25-000010.md) | [1.51](/filings/0001591698-25-000051.md) | not reported | [0.89](/filings/0001591698-25-000113.md) | [0.67](/filings/0001591698-26-000007.md) | [1.64](/filings/0001591698-26-000037.md) | not reported | [0.87](/filings/0001591698-25-000113.md) | [0.93](/filings/0001591698-26-000007.md) | [2.07](/filings/0001591698-26-000037.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [305](/filings/0001591698-24-000277.md) | [367](/filings/0001591698-25-000010.md) | [493](/filings/0001591698-25-000051.md) | [402](/filings/0001591698-26-000069.md) | [779](/filings/0001591698-25-000113.md) | [482](/filings/0001591698-26-000007.md) | [478](/filings/0001591698-26-000037.md) | [398](/filings/0001591698-26-000069.md) | [165](/filings/0001591698-25-000113.md) | [162](/filings/0001591698-26-000007.md) | [300](/filings/0001591698-26-000037.md) | [272](/filings/0001591698-26-000069.md) |
| Current assets | $m | [2,983](/filings/0001591698-23-000238.md) | [3,807](/filings/0001591698-24-000014.md) | [4,247](/filings/0001591698-24-000100.md) | [3,524](/filings/0001591698-25-000087.md) | [3,296](/filings/0001591698-24-000277.md) | [4,237](/filings/0001591698-25-000010.md) | [4,103](/filings/0001591698-25-000051.md) | [3,312](/filings/0001591698-26-000069.md) | [3,163](/filings/0001591698-25-000113.md) | [5,894](/filings/0001591698-26-000007.md) | [4,358](/filings/0001591698-26-000037.md) | [3,723](/filings/0001591698-26-000069.md) |
| Total assets | $m | [3,647](/filings/0001591698-23-000238.md) | [4,493](/filings/0001591698-24-000014.md) | [4,953](/filings/0001591698-24-000100.md) | [4,245](/filings/0001591698-25-000087.md) | [4,025](/filings/0001591698-24-000277.md) | [5,294](/filings/0001591698-25-000010.md) | [5,168](/filings/0001591698-25-000051.md) | [4,389](/filings/0001591698-26-000069.md) | [4,236](/filings/0001591698-25-000113.md) | [6,973](/filings/0001591698-26-000007.md) | [5,444](/filings/0001591698-26-000037.md) | [4,884](/filings/0001591698-26-000069.md) |
| Current liabilities | $m | [2,672](/filings/0001591698-23-000238.md) | [3,423](/filings/0001591698-24-000014.md) | [3,765](/filings/0001591698-24-000100.md) | [3,117](/filings/0001591698-25-000087.md) | [2,501](/filings/0001591698-24-000277.md) | [3,706](/filings/0001591698-25-000010.md) | [3,625](/filings/0001591698-25-000051.md) | [2,905](/filings/0001591698-26-000069.md) | [2,945](/filings/0001591698-25-000113.md) | [5,678](/filings/0001591698-26-000007.md) | [4,038](/filings/0001591698-26-000037.md) | [3,420](/filings/0001591698-26-000069.md) |
| Total liabilities | $m | [2,754](/filings/0001591698-23-000238.md) | [3,506](/filings/0001591698-24-000014.md) | [3,854](/filings/0001591698-24-000100.md) | [3,212](/filings/0001591698-25-000087.md) | [2,919](/filings/0001591698-24-000277.md) | [4,122](/filings/0001591698-25-000010.md) | [3,959](/filings/0001591698-25-000051.md) | [3,156](/filings/0001591698-26-000069.md) | [3,133](/filings/0001591698-25-000113.md) | [5,874](/filings/0001591698-26-000007.md) | [4,264](/filings/0001591698-26-000037.md) | [3,663](/filings/0001591698-26-000069.md) |
| Long-term debt | $m | not reported | not reported | not reported | [0.0](/filings/0001591698-25-000087.md) | [325](/filings/0001591698-24-000277.md) | [325](/filings/0001591698-25-000010.md) | [244](/filings/0001591698-25-000051.md) | [163](/filings/0001591698-26-000069.md) | [81.3](/filings/0001591698-25-000113.md) | [81.3](/filings/0001591698-26-000007.md) | [81.3](/filings/0001591698-26-000037.md) | [81.3](/filings/0001591698-26-000069.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [893](/filings/0001591698-25-000010.md) | [987](/filings/0001591698-25-000051.md) | [1,099](/filings/0001591698-25-000051.md) | [1,033](/filings/0001591698-26-000069.md) | [1,106](/filings/0001591698-26-000007.md) | [1,172](/filings/0001591698-26-000037.md) | [1,209](/filings/0001591698-26-000037.md) | [1,234](/filings/0001591698-26-000069.md) | [1,103](/filings/0001591698-26-000007.md) | [1,098](/filings/0001591698-26-000037.md) | [1,181](/filings/0001591698-26-000037.md) | [1,221](/filings/0001591698-26-000069.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [62.1](/filings/0001591698-24-000277.md) | [75.1 d](/filings/0001591698-25-000010.md) | [168 d](/filings/0001591698-25-000051.md) | [79.9 d](/filings/0001591698-26-000069.md) | [91.5](/filings/0001591698-25-000113.md) | [54.2 d](/filings/0001591698-26-000007.md) | [186 d](/filings/0001591698-26-000037.md) | [86.6 d](/filings/0001591698-26-000069.md) | [86.5](/filings/0001591698-25-000113.md) | [117 d](/filings/0001591698-26-000007.md) | [218 d](/filings/0001591698-26-000037.md) | [112 d](/filings/0001591698-26-000069.md) |
| Capital expenditure | $m | [3.5](/filings/0001591698-24-000277.md) | [2.7 d](/filings/0001591698-25-000010.md) | [5.6 d](/filings/0001591698-25-000051.md) | [6.3 d](/filings/0001591698-26-000069.md) | [2.3](/filings/0001591698-25-000113.md) | [3.0 d](/filings/0001591698-26-000007.md) | [2.3 d](/filings/0001591698-26-000037.md) | [5.4 d](/filings/0001591698-26-000069.md) | [3.8](/filings/0001591698-25-000113.md) | [3.4 d](/filings/0001591698-26-000007.md) | [8.4 d](/filings/0001591698-26-000037.md) | [20.6 d](/filings/0001591698-26-000069.md) |
| Share repurchases | $m | not reported | not reported | [0.0 d](/filings/0001591698-25-000051.md) | [150 d](/filings/0001591698-26-000069.md) | [0.0](/filings/0001591698-25-000113.md) | [8.4 d](/filings/0001591698-26-000007.md) | [82.7 d](/filings/0001591698-26-000037.md) | [58.6 d](/filings/0001591698-26-000069.md) | [200](/filings/0001591698-25-000113.md) | [100 d](/filings/0001591698-26-000007.md) | [50.0 d](/filings/0001591698-26-000037.md) | [48.1 d](/filings/0001591698-26-000069.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [56.7](/filings/0001591698-23-000238.md) | [56.5](/filings/0001591698-24-000014.md) | [56.6](/filings/0001591698-24-000100.md) | [56.9](/filings/0001591698-24-000277.md) | [56.9](/filings/0001591698-25-000010.md) | [57.0](/filings/0001591698-25-000051.md) | [56.3](/filings/0001591698-25-000113.md) | [56.7](/filings/0001591698-26-000007.md) | [56.8](/filings/0001591698-26-000037.md) | [55.9](/filings/0001591698-25-000113.md) | [54.8](/filings/0001591698-26-000007.md) | [54.3](/filings/0001591698-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 53,056,963 at 2026-07-29, from the cover of the [10-K filed 2026-08-05](/filings/0001591698-26-000069.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.